Quick Answer
CTT PHARMACEUTICAL HOLDINGS, INC. reported Cash and Equivalents of $81.2 thousand for fiscal year 2014.
CTT PHARMACEUTICAL HOLDINGS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2014 | $81.2K | +9763.8% |
| 2013 | $823.00 | -93.2% |
| 2012 | $12.1K | -97.9% |
| 2011 | $569.4K | +1132.7% |
| 2010 | $46.2K | -83.0% |
| 2009 | $271.2K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2015 | $32.1K | -74.4% | -30.3% |
| June 30, 2015 | $46.1K | +1155.7% | -37.3% |
| March 31, 2015 | $73.4K | +1516.0% | -9.5% |
| December 31, 2014 | $81.2K | — | -35.2% |
| September 30, 2014 | $125.3K | — | +3315.6% |
| June 30, 2014 | $3.7K | -53.7% | -19.3% |
| March 31, 2014 | $4.5K | -76.1% | — |
| December 31, 2013 | $0.00 | — | — |
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +9763.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2014 period, CTT PHARMACEUTICAL HOLDINGS, INC.’s cash and equivalents has declined by 70.1% (from $271.2 thousand to $81.2 thousand).
- The most recent figure is from CTT PHARMACEUTICAL HOLDINGS, INC.’s fiscal year 2014 report (Form 10-K), filed with the SEC on April 14, 2015.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: